Prof. Ching Lung LAI (Hong Kong)

Professor Ching-Lung Lai is the Chair Professor of Medicine and Hepatology, and the Chief of the Gastroenterology and Hepatology Division, at the Department of Medicine, University of Hong Kong, where he has been working since 1971. For the last three decades he has been extensively involved in research into various aspects of HBV, including hepatocellular carcinoma. He is one of the lead investigators in the pivotal trials of various nucleoside analogues which have revolutionized the treatment of chronic hepatitis B. He and his colleagues have also been investigating the still emerging field of the natural history of chronic hepatitis B, with findings which have important bearing on the treatment end-points for chronic hepatitis B. Professor Lai has published over 380 peer-reviewed papers and reviews in international journals. He was invited to give the Leon Schiff State-of-the-Art Lecture at the 2005 annual meeting of the American Association for the Study of Liver Diseases (AASLD), entitled “The Natural History and Treatment of Chronic Hepatitis B: Consensus and Controversies”. A second edition of the book “Hepatitis B Virus” which Professor Lai co-edited with Professor Stephen Locarnini was published in 2008 by the International Medical Press.